Successful treatment of an elderly patient with an uncommon L861Q epidermal growth factor receptor mutation with low‐dose afatinib: A case report

There are limited data on the clinical efficiency of afatinib in non‐small cell lung cancer (NSCLC) patients with uncommon epidermal growth factor receptor (EGFR) mutations. Moreover, the efficacy and safety of afatinib in elderly patients with these mutations has not been established. Here, we desc...

Descripción completa

Detalles Bibliográficos
Autores principales: Iida, Yuko, Kumasawa, Fumio, Shimizu, Tetsuo, Shintani, Yoshitaka, Takahashi, Noriaki, Gon, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996987/
https://www.ncbi.nlm.nih.gov/pubmed/31779047
http://dx.doi.org/10.1111/1759-7714.13269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996987/
https://www.ncbi.nlm.nih.gov/pubmed/31779047
http://dx.doi.org/10.1111/1759-7714.13269

Ejemplares similares